Trident Texofab will hold a meeting of the Board of Directors of the Company on 13 March 2024.Powered by Capital Market - Live News

Net profit of Trident Texofab declined 51.30% to Rs 0.56 crore in the quarter ended December 2023 as against Rs 1.15 crore during the previous quarter ended December 2022. Sales declined 6.27% to Rs 23.01 crore in the quarter ended December 2023 as against Rs 24.55 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales23.0124.55 -6 OPM %8.268.84 - PBDT1.081.99 -46 PBT0.671.59 -58 NP0.561.15 -51 Powered by Capital Market - Live News

Trident Texofab will hold a meeting of the Board of Directors of the Company on 14 February 2024.Powered by Capital Market - Live News

Net profit of Trident Texofab declined 3.85% to Rs 0.75 crore in the quarter ended September 2023 as against Rs 0.78 crore during the previous quarter ended September 2022. Sales declined 4.01% to Rs 23.20 crore in the quarter ended September 2023 as against Rs 24.17 crore during the previous quarter ended September 2022. ParticularsQuarter Ended�Sep. 2023Sep. 2022% Var. Sales23.2024.17 -4 OPM %5.438.90 - PBDT1.221.45 -16 PBT0.811.03 -21 NP0.750.78 -4 Powered by Capital Market - Live News

Trident Texofab will hold a meeting of the Board of Directors of the Company on 6 November 2023.Powered by Capital Market - Live News